HSINCHU, 25 janvier 2024 /PRNewswire/ — ICP DAS – BMP, le premier fournisseur asiatique de polyuréthane thermoplastique (TPU) de qualité médicale, fera ses débuts aux États-Unis à l’occasion du salon MD&M West. Pour lancer cette année 2024, l’entreprise présente une gamme complète de TPU…

HSINCHU, 25 janvier 2024 /PRNewswire/ — ICP DAS – BMP, le premier fournisseur asiatique de polyuréthane thermoplastique (TPU) de qualité médicale, fera ses débuts aux États-Unis à l’occasion du salon MD&M West. Pour lancer cette année 2024, l’entreprise présente une gamme complète de TPU…

NEW YORK, Jan. 25, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Future FinTech Group Inc. (“Future FinTech” or “the Company”) (NASDAQ: FTFT) and…

NEW YORK, Jan. 25, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Future FinTech Group Inc. (“Future FinTech” or “the Company”) (NASDAQ: FTFT) and…

NEW YORK, Jan. 25, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mobileye Global Inc. (“Mobileye” or “the Company”) (NASDAQ: MBLY) and certain of its…

NEW YORK, Jan. 25, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mobileye Global Inc. (“Mobileye” or “the Company”) (NASDAQ: MBLY) and certain of its…

SHANGHAI, Jan. 25, 2024 /PRNewswire/ — Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that…

SHANGHAI, Jan. 25, 2024 /PRNewswire/ — Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.